Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Global Prevalence of Cardiac Disorders such as Strokes and Coronary Heart Diseases
4.2.2 Availability of Technologically Advanced Products and Reimbursement Policies
4.3 Market Restraints
4.3.1 Adoption of Minimally Invasive Procedures like Percutaneous Coronary Interventions.
4.3.2 Highly Expensive Treatments and Lack of Advanced Healthcare Infrastructure.
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Off-pump CABG
5.1.2 On-pump CABG
5.1.3 Others
5.2 By Products and Services
5.2.1 Grafts
5.2.2 Retractors
5.2.3 Services
5.2.4 Others
5.3 By End-Users
5.3.1 Hospitals
5.3.2 Cardiology Clinics
5.3.3 Other
5.4 Geography
5.4.1 North America
5.4.1.1 United states
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Terumo Medical Corporation
6.1.2 Getinge AB
6.1.3 Genesee Biomedical Inc
6.1.4 Medtronic plc
6.1.5 Karl Storz SE & Co KG
6.1.6 Scanlan International Inc
6.1.7 Neograft Inc
6.1.8 Vitalitec International Inc
6.1.9 Edwards Lifesciences
6.1.10 Stryker Inc


7 MARKET OPPORTUNITIES AND FUTURE TRENDS